CNBC January 23, 2025
Angelica Peebles

Key Points

– Moderna is testing a norovirus vaccine in a phase three trial, with results available as soon as this year.

– Norovirus cases are on the rise this winter, with outbreaks already up more than 30% by December, per data from the Centers for Disease Control and Prevention.

– The stomach bug is highly contagious and spreads easily in nursing homes, daycares, cruise ships and other places where people are in close quarters. It’s especially dangerous for seniors.

Norovirus is raging across the U.S. this winter. Moderna might soon have a vaccine for it.

A large phase three trial of the shot is underway, with results expected as soon as later this year or 2026. Moderna needs...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
People on Ozempic may have fewer heart attacks, strokes, addictions—but more nausea, vomiting, stomach pain
Exploring the Future of Genomics and Life Sciences
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Novo Nordisk Obesity Drug Shows 22% Weight Loss, But Lack of Safety Detail Is a Sticking Point
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks

Share This Article